Skip to main content

Table 3 Comparison of clinical profiles between LLOM and non-LLOM groups

From: Diagnostic performance of quantitative Ga-SPECT/CT for patients with lower-limb osteomyelitis

 

LLOM (n = 54)

Non-LLOM (n = 49)

P value

Age (years)

68 (61–75)

64 (55–74)

0.037

Male (%)

37 (69%)

39 (80%)

0.263

Blood exam

   

 WBC count (/μl)

6250 (5100–7575)

6200 (5400–8000)

0.731

 CRP (mg/l)

1.12 (0.24–3.37)

1.62 (0.28–3.72)

0.907

Risk factor/comorbidity

   

 Diabetes mellitus (%)

37 (69%)

40 (82%)

0.173

 Peripheral artery disease (%)

31 (57%)

33 (67%)

0.317

 Cellulitis (%)

49 (91%)

32 (65%)

0.003

 Hypertension (%)

27 (50%)

25 (51%)

0.925

 Chronic kidney disease (%)

21 (39%)

28 (57%)

0.098

 Coronary artery disease (%)

10 (19%)

14 (29%)

0.331

Imaging findings

   

 Positive in planar imaging

12 (71%; n = 17)

14 (67%; n = 21)

0.796

 Positive in SPECT/CT

44 (81%)

4 (8%)

 < 0.001

 LBR

12.23 (7.38–17.94)

1.00 (1.00–1.47)

 < 0.001

 SUVmax

4.85 (3.45–8.31)

1.34 (1.14–1.62)

 < 0.001

 TLU

68.77 (22.90–96.63)

8.63 (1.15–2.33)

 < 0.001

  1. LLOM lower-limb osteomyelitis; SPECT/CT single-photon emission computed tomography/computed tomography; SUV standardized uptake value; LBR lesion-to-background ratio; and TLU total lesion uptake